147 related articles for article (PubMed ID: 37058332)
1. Relationship between anticancer sensitivities and cellular respiration properties in 5-fluorouracil-resistant HCT116 human colorectal cancer cells.
Kurasaka C; Nishizawa N; Uozumi H; Ogino Y; Sato A
FEBS Open Bio; 2023 Jun; 13(6):1125-1133. PubMed ID: 37058332
[TBL] [Abstract][Full Text] [Related]
2. Anticancer sensitivity and biological aspect of 5-fluorouracil-resistant human colorectal cancer HCT116 cells in three-dimensional culture under high- and low-glucose conditions.
Kurasaka C; Nishizawa N; Ogino Y; Sato A
Nucleosides Nucleotides Nucleic Acids; 2024 Mar; ():1-11. PubMed ID: 38555594
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms and Tumor Biological Aspects of 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells.
Kurasaka C; Ogino Y; Sato A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805673
[TBL] [Abstract][Full Text] [Related]
4. RNF38 enhances 5-Fluorouracil resistance in colorectal cancer by activating the Wnt pathway.
Long Y; Zhao Q; Huang Y
J BUON; 2021; 26(4):1246-1251. PubMed ID: 34564977
[TBL] [Abstract][Full Text] [Related]
5. Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer.
Shakibaei M; Kraehe P; Popper B; Shayan P; Goel A; Buhrmann C
BMC Cancer; 2015 Apr; 15():250. PubMed ID: 25884903
[TBL] [Abstract][Full Text] [Related]
6. Trapping of 5-Fluorodeoxyuridine Monophosphate by Thymidylate Synthase Confers Resistance to 5-Fluorouracil.
Kurasaka C; Nishizawa N; Ogino Y; Sato A
ACS Omega; 2022 Feb; 7(7):6046-6052. PubMed ID: 35224365
[TBL] [Abstract][Full Text] [Related]
7. Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells.
Ogino Y; Sato A; Kawano Y; Aoyama T; Uchiumi F; Tanuma SI
Anticancer Res; 2019 Dec; 39(12):6457-6462. PubMed ID: 31810909
[TBL] [Abstract][Full Text] [Related]
8. N
Zhang K; Zhang T; Yang Y; Tu W; Huang H; Wang Y; Chen Y; Pan K; Chen Z
Theranostics; 2022; 12(10):4802-4817. PubMed ID: 35832094
[No Abstract] [Full Text] [Related]
9. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures.
Shakibaei M; Buhrmann C; Kraehe P; Shayan P; Lueders C; Goel A
PLoS One; 2014; 9(1):e85397. PubMed ID: 24404205
[TBL] [Abstract][Full Text] [Related]
10. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
12.
Kang YH; Lee JS; Lee NH; Kim SH; Seo CS; Son CG
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806077
[TBL] [Abstract][Full Text] [Related]
13. Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells.
Ogino Y; Sato A; Uchiumi F; Tanuma SI
Genomics; 2019 Dec; 111(6):1889-1895. PubMed ID: 30582964
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer.
Buhrmann C; Shayan P; Kraehe P; Popper B; Goel A; Shakibaei M
Biochem Pharmacol; 2015 Nov; 98(1):51-68. PubMed ID: 26310874
[TBL] [Abstract][Full Text] [Related]
15. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells.
Kim HJ; An J; Ha EM
J Microbiol; 2022 Jan; 60(1):100-117. PubMed ID: 34964946
[TBL] [Abstract][Full Text] [Related]
17. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
[TBL] [Abstract][Full Text] [Related]
18. Resistance of colorectal cancer cells to 5-FUdR and 5-FU caused by Mycoplasma infection.
Jetté L; Bissoon-Haqqani S; Le François B; Maroun JA; Birnboim HC
Anticancer Res; 2008; 28(4B):2175-80. PubMed ID: 18751392
[TBL] [Abstract][Full Text] [Related]
19. SPOCK1 silencing decreases 5-FU resistance through PRRX1 in colorectal cancer.
Qu YL; Liu XL; Zhao SY; Zhai XF
Pathol Res Pract; 2022 Jun; 234():153895. PubMed ID: 35462225
[TBL] [Abstract][Full Text] [Related]
20. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil.
Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]